CNADF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Apr 10 closing price
Capitalization
30.01M
HLNCF
Price
$4.90
Change
-$0.03 (-0.61%)
Updated
Jul 25 closing price
Capitalization
39.92B
Interact to see
Advertisement

CNADF vs HLNCF

Header iconCNADF vs HLNCF Comparison
Open Charts CNADF vs HLNCFBanner chart's image
CANADABIS CAP
Price$0.06
Change-$0.00 (-0.00%)
Volume$6K
Capitalization30.01M
HALEON
Price$4.90
Change-$0.03 (-0.61%)
Volume$2.46K
Capitalization39.92B
CNADF vs HLNCF Comparison Chart in %
Loading...
HLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNADF vs. HLNCF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNADF is a Hold and HLNCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (CNADF: $0.06 vs. HLNCF: $4.90)
Brand notoriety: CNADF and HLNCF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CNADF: 100% vs. HLNCF: 21%
Market capitalization -- CNADF: $30.01M vs. HLNCF: $39.92B
CNADF [@Pharmaceuticals: Other] is valued at $30.01M. HLNCF’s [@Pharmaceuticals: Other] market capitalization is $39.92B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNADF’s FA Score shows that 1 FA rating(s) are green whileHLNCF’s FA Score has 0 green FA rating(s).

  • CNADF’s FA Score: 1 green, 4 red.
  • HLNCF’s FA Score: 0 green, 5 red.
According to our system of comparison, CNADF is a better buy in the long-term than HLNCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLNCF’s TA Score shows that 5 TA indicator(s) are bullish.

  • HLNCF’s TA Score: 5 bullish, 2 bearish.

Price Growth

CNADF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while HLNCF (@Pharmaceuticals: Other) price change was +2.62% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLNCF($39.9B) has a higher market cap than CNADF($30M). CNADF YTD gains are higher at: 78.571 vs. HLNCF (4.701). HLNCF has higher annual earnings (EBITDA): 2.06B vs. CNADF (4.73M). HLNCF has more cash in the bank: 606M vs. CNADF (2.79M). CNADF has less debt than HLNCF: CNADF (6.97M) vs HLNCF (10.4B). HLNCF has higher revenues than CNADF: HLNCF (11.2B) vs CNADF (21.6M).
CNADFHLNCFCNADF / HLNCF
Capitalization30M39.9B0%
EBITDA4.73M2.06B0%
Gain YTD78.5714.7011,671%
P/E RatioN/A27.25-
Revenue21.6M11.2B0%
Total Cash2.79M606M0%
Total Debt6.97M10.4B0%
TECHNICAL ANALYSIS
Technical Analysis
CNADFHLNCF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
33%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
41%
Bearish Trend 2 days ago
45%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
70%
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
54%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
45%
View a ticker or compare two or three
Interact to see
Advertisement
HLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RNA36.273.06
+9.21%
Avidity Biosciences
TLSA1.860.12
+6.90%
Tiziana Life Sciences Ltd
ALL195.701.76
+0.91%
Allstate Corp (The)
NCDL16.89-0.04
-0.24%
Nuveen Churchill Direct Lending Corp
ELBM1.29N/A
-0.39%
Electra Battery Matls Corp

CNADF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNADF has been loosely correlated with CHSYF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CNADF jumps, then CHSYF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNADF
1D Price
Change %
CNADF100%
N/A
CHSYF - CNADF
38%
Loosely correlated
N/A
ZTS - CNADF
24%
Poorly correlated
-0.46%
CPHI - CNADF
20%
Poorly correlated
+1.34%
CLSH - CNADF
6%
Poorly correlated
N/A
ESAIY - CNADF
5%
Poorly correlated
-0.28%
More

HLNCF and

Correlation & Price change

A.I.dvisor tells us that HLNCF and STEK have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLNCF and STEK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLNCF
1D Price
Change %
HLNCF100%
-0.51%
STEK - HLNCF
12%
Poorly correlated
-9.12%
HLBBF - HLNCF
8%
Poorly correlated
-3.38%
BNXTF - HLNCF
6%
Poorly correlated
N/A
HLUBF - HLNCF
5%
Poorly correlated
N/A
CNADF - HLNCF
4%
Poorly correlated
N/A
More